[ORGANIZATION]
NeuroPace
Featured in 2 tracked stories · first seen
Situations
Neuroscience company earnings and analyst updates
2 clusters · 2 sources · last updated
Latest: Promis Neurosciences and NeuroPace see updated analyst earnings estimates
Analysts have updated earnings per share (EPS) estimates for neuroscience-focused companies Promis Neurosciences and NeuroPace. Brookline Capital Markets raised the Q3 2026 EPS forecast for Promis Neurosciences to ($1.
Also covered in
-
NeuroPace FDA Review Delays Expanded Epilepsy Device Approval, Seeks More Data
[HEALTH] · 4 sources ·